Cite
Patil V, Noronha V, Joshi A, et al. Phase III Non-inferiority Study Evaluating Efficacy and Safety of Low Dose Gemcitabine Compared to Standard Dose Gemcitabine With Platinum in Advanced Squamous Lung Cancer. EClinicalMedicine. 2019;9:19-25doi: 10.1016/j.eclinm.2019.03.011.
Patil, V., Noronha, V., Joshi, A., Chougule, A., Kannan, S., Bhattacharjee, A., Goud, S., More, S., Chandrasekharan, A., Menon, N., Srinivas, S., Vallathol, D. H., Dsouza, H., Majumdar, S., Das, S., Zawar, A., Khaddar, S., Kumar, A., Singh, G., Kumar, K. A. P., Ravind, R., Trivedi, V., Behel, V., Mahajan, A., Janu, A., Purandare, N., & Prabhash, K. (2019). Phase III Non-inferiority Study Evaluating Efficacy and Safety of Low Dose Gemcitabine Compared to Standard Dose Gemcitabine With Platinum in Advanced Squamous Lung Cancer. EClinicalMedicine, 919-25. https://doi.org/10.1016/j.eclinm.2019.03.011
Patil, Vijay, et al. "Phase III Non-inferiority Study Evaluating Efficacy and Safety of Low Dose Gemcitabine Compared to Standard Dose Gemcitabine With Platinum in Advanced Squamous Lung Cancer." EClinicalMedicine vol. 9 (2019): 19-25. doi: https://doi.org/10.1016/j.eclinm.2019.03.011
Patil V, Noronha V, Joshi A, Chougule A, Kannan S, Bhattacharjee A, Goud S, More S, Chandrasekharan A, Menon N, Srinivas S, Vallathol DH, Dsouza H, Majumdar S, Das S, Zawar A, Khaddar S, Kumar A, Singh G, Kumar KAP, Ravind R, Trivedi V, Behel V, Mahajan A, Janu A, Purandare N, Prabhash K. Phase III Non-inferiority Study Evaluating Efficacy and Safety of Low Dose Gemcitabine Compared to Standard Dose Gemcitabine With Platinum in Advanced Squamous Lung Cancer. EClinicalMedicine. 2019 Apr 09;9:19-25. doi: 10.1016/j.eclinm.2019.03.011. eCollection 2019 Mar. PMID: 31143878; PMCID: PMC6510888.
Copy
Download .nbib